LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Nuray Chemicals Private Limited
03 1HRV Global Life Sciences
04 1Neuland Laboratories
05 2TAPI Technology & API Services
06 1American Pacific Corporation
07 1Aspire Lifesciences Pvt Ltd
08 1COSMA S.p.A
09 1Cadila Pharmaceuticals
10 1Cambrex Corporation
11 1Erregierre SpA
12 1Flamma SpA
13 1GSK
14 1Glenmark Life Sciences
15 1Glenmark Pharmaceuticals
16 1Macleods Pharmaceuticals Limited
17 1Olon S.p.A
18 2Procos
19 1Sicor Societa Italiana Corticosteroidi Srl
20 1Sifavitor srl
21 1Solara Active Pharma Sciences
22 1Sriam Labs
23 1Srini Pharmaceuticals
24 1Symed Labs
25 1UQUIFA
26 1Unichem Laboratories Limited
27 1Unipex
28 1Viatris
29 1Viyash Life Sciences
30 1Zydus Lifesciences
01 1France
02 15India
03 2Israel
04 8Italy
05 1Spain
06 4U.S.A
07 1United Kingdom
01 14Active
02 5Inactive
03 13Blank
01 5Valid
02 2Withdrawn by Holder
03 25Blank
01 1218MF10819
02 1218MF10992
03 1224MF10101
04 1226MF10014
05 28Blank
01 1WC-0037
02 1WC-0074
03 1WC-0228
04 1WC-0313
05 28Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-01-31
Pay. Date : 2017-01-11
DMF Number : 30564
Submission : 2016-06-07
Status : Active
Type : II
Certificate Number : CEP 2016-222 - Rev 04
Issue Date : 2024-05-07
Type : Chemical
Substance Number : 923
Status : Valid
Date of Issue : 2022-06-08
Valid Till : 2025-06-16
Written Confirmation Number : WC-0037
Address of the Firm :
NDC Package Code : 58032-2025
Start Marketing Date : 2016-07-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10901
Submission : 1994-05-18
Status : Inactive
Type : II
Registration Number : 218MF10819
Registrant's Address : Via Messina, 38, 20154 Milano Italy
Initial Date of Registration : 2006-10-06
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-06
Pay. Date : 2014-03-04
DMF Number : 16314
Submission : 2002-12-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38064
Submission : 2023-03-30
Status : Active
Type : II
NDC Package Code : 66039-962
Start Marketing Date : 2022-08-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-09-07
Pay. Date : 2023-07-26
DMF Number : 37306
Submission : 2022-08-09
Status : Active
Type : II
Certificate Number : CEP 2022-315 - Rev 00
Issue Date : 2024-08-23
Type : Chemical
Substance Number : 923
Status : Valid
NDC Package Code : 82245-0203
Start Marketing Date : 1987-04-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23710
Submission : 2010-04-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17319
Submission : 2004-04-13
Status : Inactive
Type : II
We have 30 companies offering Labetalol Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?